| Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan … YH Lee, WR Chiou, CY Hsu, PL Lin, HW Liang, FP Chung, CT Liao, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (2), 118-129, 2022 | 30 | 2022 |
| 2023 Guidelines of the Taiwan Society of Cardiology on the diagnosis and management of chronic coronary syndrome KC Ueng, CE Chiang, TH Chao, YW Wu, WL Lee, YH Li, KH Ting, CH Su, ... Acta Cardiologica Sinica 39 (1), 4, 2023 | 29 | 2023 |
| Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction YH Lee, PL Lin, WR Chiou, JL Huang, WY Lin, CT Liao, FP Chung, ... ESC heart failure 8 (2), 1204-1215, 2021 | 18 | 2021 |
| Effect of radiofrequency-based renal denervation: the impact of unplanned medication change from a systematic review and meta-analysis LYM Liu, PL Lin, FC Liao, SI Lin, WR Chiou, YJ Wu, YH Lee Acta Cardiologica Sinica 35 (2), 144, 2019 | 14 | 2019 |
| Safety and effectiveness of rivaroxaban in combination with various antiarrhythmic drugs in patients with non-permanent atrial fibrillation WR Chiou, CC Huang, PL Lin, JY Chuang, LYM Liu, MI Su, FC Liao, ... American Journal of Cardiovascular Drugs, 1-11, 2021 | 11 | 2021 |
| 2023 Consensus of Taiwan Society of Cardiology on the pharmacological treatment of chronic heart failure CE Chiang, CL Hung, YW Wu, TH Lin, KC Ueng, SH Sung, CK Wu, ... Acta Cardiologica Sinica 39 (3), 361, 2023 | 9 | 2023 |
| Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: rationale and baseline characteristics of the TAROT-HF study WY Lin, FP Chung, CT Liao, JL Huang, HW Liang, YH Lee, PL Lin, ... Journal of the Chinese Medical Association 84 (9), 833-841, 2021 | 9 | 2021 |
| Risks and outcomes of critical limb ischemia in hemodialysis patients: a prospective cohort study MY Hsieh, SY Chuang, CK Lee, CM Luo, CH Cheng, MT Liao, PL Lin, ... Clinical Kidney Journal 16 (3), 585-595, 2023 | 6 | 2023 |
| Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy HT Huang, JL Huang, PL Lin, YH Lee, CY Hsu, FP Chung, CT Liao, ... ESC heart failure 9 (6), 3825-3835, 2022 | 6 | 2022 |
| Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan CY Hsu, HY Chang, CJ Chao, WR Chiou, PL Lin, FP Chung, WY Lin, ... Frontiers in Cardiovascular Medicine 9, 950389, 2022 | 6 | 2022 |
| The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: medical expenses and clinical effectiveness HW Liang, CT Liao, WY Lin, FP Chung, JL Huang, YH Lee, PL Lin, ... Journal of the Chinese Medical Association 84 (6), 588-595, 2021 | 6 | 2021 |
| Relations between baseline burden, maximum duration, and relative reduction of atrial fibrillation: Insights from continuous monitoring in rhythm control PL Lin, CC Huang, YJ Wu, MI Su, WR Chiou, LYM Liu, FC Liao, E Lai, ... Journal of Cardiovascular Electrophysiology 30 (2), 178-182, 2019 | 6 | 2019 |
| 2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction YH Li, CC Wang, CL Hung, YW Wu, CH Hsu, YL Tsou, CH Wang, CK Wu, ... Acta Cardiologica Sinica 40 (2), 148, 2024 | 4 | 2024 |
| Real-world analyses of the treatment conditions in patients initiating proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor in Taiwan PL Lin, YW Wu, CF Lin, HI Yeh, WT Chang, MJ Charng, PH Huang, ... Journal of Atherosclerosis and Thrombosis 30 (9), 1123-1131, 2023 | 4 | 2023 |
| Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation WR Chiou, PL Lin, CC Huang, JY Chuang, LYM Liu, MI Su, FC Liao, ... Scientific Reports 12 (1), 3745, 2022 | 4 | 2022 |
| Preliminary study a non-invasion method on early cardiac energy defect based on Hilbert Huang Transform PL Lin, KY Chen, H Ma, CL Wang, YJ Lin Medical Hypotheses 144, 110205, 2020 | 4 | 2020 |
| Effects of lorcaserin on cardiometabolic risk factors in overweight and obese patients: A systematic review and meta‐analysis HH Kuo, KT Wang, YH Lee, PL Lin, ME Liu, CY Lin, LYM Liu Journal of Clinical Pharmacy and Therapeutics 45 (1), 35-44, 2020 | 4 | 2020 |
| Effectiveness of a non-taped compression dress in patients receiving cardiac implantable electronic devices CY Chien, YH Chang, YJ Wu, PL Lin, WR Chiou, BC Chi, HP Wu, FC Liao, ... Acta Cardiologica Sinica 35 (3), 320, 2019 | 4 | 2019 |
| 2024 guidelines of the Taiwan society of cardiology on the primary prevention of atherosclerotic cardiovascular disease---Part I TH Chao, TH Lin, CI Cheng, YW Wu, KC Ueng, YJ Wu, WW Lin, HB Leu, ... Acta Cardiologica Sinica 40 (5), 479, 2024 | 3 | 2024 |
| Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction HP Sung, CY Hsu, YH Lee, PL Lin, CT Liao, FP Chung, SL Ko, CY Huang, ... Journal of the Chinese Medical Association 86 (8), 725-731, 2023 | 3 | 2023 |
Ying-Hsiang Lee 李應湘MacKay Memorial Hospital, Taipei, Taiwan在 mmh.org.tw 的电子邮件经过验证
Ying-Hsiang Lee 李應湘MacKay Memorial Hospital, Taipei, Taiwan在 mmh.org.tw 的电子邮件经过验证
Wei-Ru Chiou (邱威儒)Division of Cardiology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taiwan在 mmh.org.tw 的电子邮件经过验证